Sacral nerve stimulation (SNS) is a medical electrical stimulation therapy that is used to treat long-term bowel control and bladder control symptoms through the modulation of nerves controlling the lower urinary tract and pelvic floor.
The external SNS device is one of the fastest growing product segments in the global sacral nerve stimulation market. Although there is just one external device available in the market, it is FDA approved and has the CE mark. However, this device is completely new to the market in APAC as implantable SNS devices are more popular compared with external SNS devices. With the introduction of new SNS devices by companies such as Nuvectra and Axonics Modulation Technologies, this segment is anticipated to have a positive outlook in the coming years.
The hospitals segment was the highest revenue contributing segment in the sacral nerve stimulation market. The complexity of the device, the need for technical expertise, and high procedure cost are some of the factors that will promote the increased adoption of SNS devices in hospitals.
The global Sacral Nerve Stimulation Devices market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Sacral Nerve Stimulation Devices market based on company, product type, end user and key regions.
This report studies the global market size of Sacral Nerve Stimulation Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Sacral Nerve Stimulation Devices in these regions.
This research report categorizes the global Sacral Nerve Stimulation Devices market by top players/brands, region, type and end user. This report also studies the global Sacral Nerve Stimulation Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
St. Jude Medical
Axonics Modulation Technologies
Codman & Shurtleff, Inc
Market size by Product
Implantable SNS Devices
External SNS Devices
Market size by End User
Market size by Region
Central & South America
Rest of Central & South America
Middle East & Africa
The study objectives of this report are:
To study and analyze the global Sacral Nerve Stimulation Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Sacral Nerve Stimulation Devices market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Sacral Nerve Stimulation Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Sacral Nerve Stimulation Devices submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Sacral Nerve Stimulation Devices are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Sacral Nerve Stimulation Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.